|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00512 GRAND PHARMA
Nominal 
4.600 +0.040 (+0.877%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 8.377% | 9.576% | 12.631% | 11.642% | 8.429% |
| ROAE (%) | 12.834% | 15.105% | 19.508% | 18.279% | 14.788% |
| Return on Capital Employed (%) | 11.201% | 13.065% | 15.510% | 14.136% | 11.258% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 61.959% | 62.239% | 61.029% | 63.517% | 61.320% |
| EBITDA Margin (%) | 28.100% | 32.140% | 35.235% | 37.716% | 28.123% |
| Pre-tax Profit Margin (%) | 22.263% | 26.321% | 32.401% | 32.640% | 20.574% |
| Net Profit Margin (%) | 17.854% | 21.746% | 27.943% | 28.218% | 17.463% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.224 X | 1.067 X | 1.218 X | 1.236 X | 1.063 X |
| Quick Ratio (X) | 0.982 X | 0.859 X | 1.017 X | 1.014 X | 0.836 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 32.177% | 36.486% | 36.160% | 33.208% | 38.385% |
| Total Debt / Total Assets (%) | 15.120% | 20.005% | 17.313% | 14.062% | 14.948% |
| Net Debt / Total Assets (%) | 9.169% | 13.550% | 8.989% | 3.248% | 7.280% |
| Total Debt / Shareholders' Funds (%) | 22.459% | 31.649% | 27.221% | 21.250% | 24.654% |
| Long Term Debt / Shareholders' Funds (%) | 6.938% | 8.645% | 11.375% | 7.240% | 12.831% |
| Net Debt / Shareholders' Funds (%) | 13.620% | 21.437% | 14.133% | 4.908% | 12.007% |
| Net Cash / (Debt) ($) | (2.065B) | (3.031B) | (1.893B) | (551.683M) | (1.006B) |
| Net Cash / (Debt) per share ($) | (0.582) | (0.854) | (0.533) | (0.155) | (0.298) |
| Total Debt / Capital Employed (%) | 20.283% | 28.117% | 23.534% | 18.834% | 20.197% |
| Interest Coverage Ratio (X) | 12.427 X | 19.306 X | 30.967 X | 18.965 X | 10.256 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 124.344 Day | 124.215 Day | 112.878 Day | 139.347 Day | 113.447 Day |
| Receivables Turnover (Day) | 68.102 Day | 70.823 Day | 70.155 Day | 83.421 Day | 73.059 Day |
| Payables Turnover (Day) | 38.187 Day | 30.677 Day | 29.652 Day | 42.998 Day | 52.340 Day |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 1,557,945 |
| %Change | 51.352% |
| EPS / (LPS) | HKD 0.444 |
| NBV Per Share ($) | HKD 4.428 |